Status:
NOT_YET_RECRUITING
Etiological Classification-guided Individual Intervention in Primary Hypertension
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Hypertension
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Eligible participants will first undergo a 1-week home blood pressure diary and 24-hour ambulatory blood pressure assessment. After a confirmed diagnosis of hypertension, etiological subtyping will be...
Eligibility Criteria
Inclusion
- Age 18-65 years.
- Diagnosed primary hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg).
- signed informed consent.
Exclusion
- Secondary hypertension or arrhythmias affecting blood pressure accuracy (e.g., atrial fibrillation).
- Comorbidities such as diabetes, chronic kidney disease (eGFR \< 30 mL/min/1.73m²), coronary artery disease, heart failure, or serious valvular heart disease.
- History of stroke or myocardial infarction.
- Pregnancy, breastfeeding, or planning to become pregnant.
- Life expectancy \< 1 year.
- Participation in another clinical trial.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06941935
Start Date
June 1 2025
End Date
December 31 2030
Last Update
April 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200072
2
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200092